Clinical Data

Wall Street IPO initial public offering markets shares stock

Biotech

Arcturus' stock halves on cystic fibrosis readout

The findings have sent the biopharma’s stock crashing, falling 55% from $23.16 per share to $10.44 per share.

Gabrielle Masson Oct 22, 2025 1:01pm

On target clinical trial success bullseye score

Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off

Oct 22, 2025 10:35am

Make a delay and accumulation of outstanding tasks Full stop

Terns mothballs obesity program after phase 2 data fall short

Oct 22, 2025 7:15am

Businessman climbing steps to pluck a star from the sky

GSK unveils pivotal data on oral antibiotic ahead of FDA filing

Oct 21, 2025 10:55am

An arrow incrementally going up stairs before pointing straight up Blue background

ESMO: Daiichi, Merck move ovarian cancer ADC toward pivotal test

Oct 20, 2025 10:45am

positive negative up down good bad mixed

Roche heads to FDA as eye disease trials yield mixed data

Oct 20, 2025 9:28am